Aurobindo Pharma Completes US FDA Inspection at Eugia Unit-I with Four Observations
Aurobindo Pharma Limited announced the completion of a United States Food and Drug Administration (US FDA) inspection at Unit-I of […]
AUROBINDO-PHARMA
CuraTeQ Biologics Ends Licensing Agreement With BioFactura for Ustekinumab Biosimilar
CuraTeQ Biologics Private Limited, the biologics-focused subsidiary of Aurobindo Pharma Limited, has decided to mutually terminate its licensing agreement with […]
Aurobindo Pharma Arm Extends Negotiations Deadline with MSD for Contract Manufacturing Operations
Aurobindo Pharma, a leading pharmaceutical company, has announced the extension of negotiations between its subsidiary, CuraTeQ Biologics, and Merck Sharp […]
Aurobindo Pharma launches HIV treatment tablet for children
Aurobindo Pharma Ltd has introduced an innovative HIV triple combination tablet specially designed for children living with HIV in low- […]
Aurobindo Pharma completes the installation of its new plant in China
Santhanam Subramanian, Chief Financial Officer of Aurobindo Pharma, announced that the installation of their plant in China has been completed, […]
Aurobindo Pharma expects to commercialise vaccine facility by Apr-May next year
Aurobindo Pharma, Hyderabad-based drug major, expects to commercialise its vaccine manufacturing facility in Hyderabad by April-May next year, according to […]
Initiating talks over Ranitidine’s impurities: Aurobindo Pharma USA
Aurobindo Pharma USA, Inc. is known to have informed the USA Food and Drug Administration of conducting a voluntary recall […]
Aurobindo Pharma to acquire Australian pharma firm for $12.5 mn
Aurobindo Pharma has said it’s wholly-owned subsidiary has entered into an agreement to acquire a product under development and related […]
Aurobindo Pharma acquires Apotexs businesses for 74 million euros
Aurobindo Pharma has signed an agreement to acquire Apotexs businesses in Czech Republic, Poland, Spain, Belgium and Netherlands for 74 […]
Aurobindo Pharma’s API expansion to create 600 new jobs
Leading Indian pharmaceutical research company Aurobindo Pharma is planning to expand its Active Pharmaceuticals Ingredients (API) manufacturing capacity, providing direct […]
USFDA nod to Aurobindo Pharma for manufacturing HIV drug
Hyderabad-based pharmaceutical major Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to make abacavir […]
Aurobindo Pharma inks 135-mn deal to buy Portugal’s Generis
Hyderabad-based Indian pharmaceutical major Aurobindo Pharma has signed a 135-million euro deal to buy Generis Farmaceutica SA, a company that […]
Aurobindo Pharma looks to acquire Portugal’s Generis
India’s leading pharma company Aurobindo, which is in an expansion mode, is likely to to buy Portuguese pharma company Generis. […]
